G. Petővári

发表

The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells

N. Nagy, L. Kopper, A. Sebestyén, 2018, Pathology & Oncology Research.

SPOCK1 Promotes the Development of Hepatocellular Carcinoma

I. Kovalszky, A. Kiss, K. Karászi, 2022, Frontiers in Oncology.

Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells

J. Pápay, A. Sebestyén, A. Jeney, 2019, Pathology & Oncology Research.

Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response

F. Sipos, A. Sebestyén, G. Műzes, 2022, PloS one.

Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines

É. Kiss, T. Krenács, Gertrud Forika, 2021, Pathology & Oncology Research.

Intratumoral Cellular Heterogeneity Critically Determines Extracellular Vesicle Uptake in Colorectal Cancer

E. Buzás, P. Lőrincz, Zoltán Wiener, 2021 .

Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting

J. Pápay, A. Sebestyén, T. Dankó, 2022, International journal of molecular sciences.

Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics

E. Sebestyén, K. Mészáros, J. Pápay, 2022, International journal of molecular sciences.

Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma

N. Nagy, Z. Sápi, T. Micsik, 2020, Cancers.

Extracellular Vesicle-Mediated Metastasis Suppressors NME1 and NME2 Modify Lipid Metabolism in Fibroblasts

E. Buzás, I. Petit, H. Butz, 2022, Cancers.

GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas

W. Leenders, L. Tretter, K. Mészáros, 2018, Journal of Experimental & Clinical Cancer Research.

Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response

F. Sipos, Á. Simon, A. Sebestyén, 2022, Pathology & Oncology Research.

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

N. Nagy, K. Mészáros, Fanni Tóth, 2018, Cancer Cell International.

Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice

I. Kovalszky, G. Szabó, A. Kiss, 2021, Cancers.

The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues

A. Sebestyén, A. Jeney, T. Dankó, 2021, Cancer and Metastasis Reviews.

Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells

P. Lőrincz, G. Barna, A. Sebestyén, 2021, International journal of molecular sciences.

In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy

A. Tőkés, J. Kulka, A. Sebestyén, 2020, Cancers.

3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures

A. Sebestyén, T. Dankó, G. Petővári, 2023, Pathology & Oncology Research.

IFITM1 expression determines extracellular vesicle uptake in colorectal cancer

E. Buzás, P. Lőrincz, Ádám Oszvald, 2021, Cellular and Molecular Life Sciences.

Formation of a protein corona on the surface of extracellular vesicles in blood plasma

Á. Kittel, E. Buzás, Y. Gho, 2021, Journal of extracellular vesicles.

The SDHB Arg230His mutation causing familial paraganglioma alters glycolysis in a new Caenorhabditis elegans model

A. Mehta, L. Tretter, A. Nazir, 2020, Disease Models & Mechanisms.

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

L. Drahos, Olivér Ozohanics, A. Sebestyén, 2017, Journal of Experimental & Clinical Cancer Research.

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer

I. Kovalszky, M. Götte, K. Baghy, 2023, Cancers.

Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro

Z. Benyó, A. Balogh, T. Krenács, 2020, International journal of molecular sciences.

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

N. Nagy, L. Drahos, Olivér Ozohanics, 2017, Journal of experimental & clinical cancer research : CR.

BMP-induced non-canonical signaling is upregulated during autophagy-mediated regeneration in inflamed mesothelial cells

A. Sebestyén, G. Petővári, Nikolett Dóczi, 2023, Scientific reports.

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

N. Nagy, K. Mészáros, Fanni Tóth, 2018, Cancer Cell International.

Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts

I. Kovalszky, K. Pálóczi, Lilla Turiák, 2023, International journal of molecular sciences.

Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFβ-ERK signaling

S. Póliska, E. Janka, G. Petővári, 2024, GeroScience.

mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies

T. Dankó, G. Petővári, Viktória Varga, 2024, Pathology oncology research : POR.

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas

G. Végső, Á. Márk, T. Dankó, 2024, British journal of cancer.

The SDHB Arg230His mutation causing familial paraganglioma alters glycolysis in a new Caenorhabditis elegans model

A. Nazir, K. Mészáros, A. Sarkar, 2020 .